Rheumatoid arthritis
Not recommended
Cat's claw is an over-the-counter herbal extract. The double-blind RCT by Mur (J Rheumatol 2002) in 40 patients with rheumatoid arthritis on stable sulfasalazine or hydroxychloroquine: a pentacyclic oxindole Uncaria tomentosa extract (Saventaro 60 mg/day for 24 weeks) reduced the tender joint count by a mean 53% versus 24% in the placebo group. Study quality is moderate, sample size small and the effect has not been reproduced in large RCTs. A small RCT by Piscoya (Inflamm Res 2001) in knee osteoarthritis showed moderate pain reduction with Uncaria guianensis (a related species) 100 mg/day for 4 weeks. 2022 and SER 2019 recommend methotrexate as first line in rheumatoid arthritis and, when needed, biological or targeted synthetic DMARDs (adalimumab, tofacitinib). Cat's claw is not mentioned in international or Spanish rheumatology guidelines and is considered an add-on, not a replacement for DMARDs. If cat's claw is considered instead of prescribed methotrexate, discuss with a rheumatologist – untreated rheumatoid arthritis progresses with joint destruction within the first or second year.
Sources
- J Rheumatol (Mur et al.): Randomized double blind trial of an extract from the pentacyclic alkaloid-chemotype of Uncaria tomentosa for the treatment of rheumatoid arthritis (2002)
- Inflamm Res (Piscoya et al.): Efficacy and safety of freeze-dried cat's claw in osteoarthritis of the knee: mechanisms of action of the species Uncaria guianensis (2001)
- EULAR: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological DMARDs (2022)